Loading...
XNAS
CBLL
Market cap703mUSD
Jul 09, Last price  
19.64USD
1D
1.24%
1Q
8.21%
IPO
-22.98%
Name

CeriBell Inc

Chart & Performance

D1W1MN
XNAS:CBLL chart
P/E
P/S
7.90
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
89m
+36.09%
25,922,00045,225,00065,444,00089,063,000
Net income
-53m
L+32.03%
-37,164,000-29,464,000-40,455,000-53,412,000
CFO
-41m
L+16.45%
-32,002,000-29,159,000-35,043,000-40,808,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
IPO date
Oct 11, 2024
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2025‑122024‑122023‑122022‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT